Preview
Are expensive, complicated, and sometimes risky techniques always necessary to assess a patient's condition after myocardial infarction? Not according to the author, who discusses variations in the management of three typical patients and also endorses a cost-saving algorithmic guide to testing and treatment of infarction survivors.